Inhibition of food intake in obese subjects by peptide YY3-36

New England Journal of Medicine

Volumn 349, Issue 10, 2003, Pages 941-948

  Batterham, Rachel L ^a   Cohen, Mark A ^a   Ellis, Sandra M ^a   Le Roux, Carel W ^a   Withers, Dominic J ^a   Frost, Gary S ^a   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; INSULIN; LEPTIN; PEPTIDE YY;

ADULT; APPETITE; ARTICLE; BODY MASS; CALORIC INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FEMALE; FOOD INTAKE; HUMAN; INSULIN BLOOD LEVEL; MALE; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL;

APPETITE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EATING; FEMALE; HUMANS; INSULIN; LEPTIN; MALE; OBESITY; PEPTIDE HORMONES; PEPTIDE YY;

EID: 0041859261     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa030204     Document Type: Article

References (26)

1. Peeters A, Barendregt JJ, Willekens F, Mackenbach JP, Al Mamun A, Bonneux L. Obesity in adulthood and its consequences for life expectancy: a life-table analysis. Ann Intern Med 2003;138:24-32.
2. Blackburn G. Effect ofdegree ofweight loss on health benefits. Obes Res 1995;3: Suppl 2:211s-216s.
3. Trostler N, Mann A, Zilberbush N, Avinoach E, Charuzi II. Weight loss and food intake 18 months following vertical banded gastroplasty or gastric bypass for severe obesity. Obes Surg 1995;5:39-51.
4. Batterham R.L, Cowley MA, Small CJ, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 2002;418:650-4.
5. Chicurel M. Whatever happened to leptin? Nature 2000;404:538-40.
6. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000;404:661-71.
7. Van Strien T, Rookus MA, Bergers GP, Frijters JE, Defares PB. Life events, emotional eating and change in body mass index. Int J Obes 1986;10:29-35.
8. Garner DM, Garfinkel PE. The Eating Attitudes Test: an index of the symptoms of anorexia nervosa. Psychol Med 1979;9:273-9.
9. Raben A, Tagliabue A, Astrup A. The reproducibility of subjective appetite scores. Br J Nutr 1995;73:517-30. [Erratum, Br J Nutr 1995;74:283.]
10. Savage AP, Adrian TE, Carolan G, Chatterjee VK, Bloom SR. Effects of peptide YY (PYY) on mouth to caecum intestinal transit time and on the rate of gastric emptying in healthy volunteers. Gut 1987;28:166-70.
11. Adrian TE, Savage AP, Fuessl HS, Wolfe K, Besterman HS, Bloom SR. Release of peptide YY (PYY) after resection of small bowel, colon, or pancreas in man. Surgery 1987;101:715-9.
12. Fuessl HS, Adrian TE, Uttenthal LO, Bloom SR. Peptide YY in diabetics treated chronically with an intestinal glucosidase inhibitor. Klin Wochenschr 1988;66:985-9.
13. Adrian TE, Bloom SR, Bryant MG, Polak JM, Heitz PH, Barnes AJ. Distribution and release of human pancreatic polypeptide. Gut 1976;17:940-4.
14. Kreymann B, Williams G, Ghatei MA, Bloom SR. Glucagon-like peptide-1 7-36: a physiological incretin in man. Lancet 1987;2:1300-4.
15. Adrian TE, Ferri GL, Bacarese-Hamilton AJ, Fuessl HS, Polak JM, Bloom SR. Human distribution and release of a putative new gut hormone, peptide YY. Gastroenterology 1985;89:1070-7.
16. Cowley MA, Smart JL, Rubinstein M, et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 2001;411:480-4.
17. Schwartz MW, Morton GJ. Obesity: keeping hunger at bay, Nature 2002;418:595-7.
18. Saper CB, Chou TC, Elmquist JK. The need to feed: homeostatic and hedonic control of eating. Neuron 2002;36:199-211.
19. Imamura M. Effects ofsurgical manipulation of the intestine on peptide YY and its physiology. Peptides 2002;23:403-7.
20. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001;50:1714-9.
21. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001;50:2540-7.
22. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001;86:5992.
23. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000;407:908-13.
24. Mun EC, Blackbum GL, Matthews JB. Current status of medical and surgical therapy for obesity. Gastroenterology 2001;120:669-81.
25. Cummings DE, Weigle DS, Frayo KS, et al. Plasma ghrelin levels after diet-induced weight loss of gastric bypass surgery. N Engl J Med 2002;346:1623-30.11
26. Naslund E, Gryback P, Hellstrom PM, et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord 1997;21:387-92.